Checkmate Pharmaceuticals is a clinical-stage biopharmaceutical company focused upon activation of innate immunity to treat cancer.
View all
Neuron23
Series C • South San Francisco, United States
Apollomics
Series C • Foster City, United States
Xilio Therapeutics
Series C • Waltham, United States
Enko
Series C • Stonington, United States
Cullinan
Series C • Cambridge, United States
Adagio Therapeutics
Series C • Waltham, United States
Vizgen
Series C • Cambridge, United States
Encodia
Series C • San Diego, United States
Halo Labs
Series C • Philadelphia, United States
HotSpot Therapeutics
Series C • Boston, United States
BioAge
Series C • Richmond, United States
DiscGenics
Series C • Salt Lake City, United States